KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 120 filers reported holding KRYSTAL BIOTECH INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,391,108 | -15.9% | 20,613 | -14.9% | 0.00% | 0.0% |
| Q2 2023 | $2,842,137 | +49.3% | 24,209 | +1.8% | 0.00% | +33.3% |
| Q1 2023 | $1,903,026 | -0.5% | 23,770 | -1.5% | 0.00% | 0.0% |
| Q4 2022 | $1,912,054 | +15.0% | 24,136 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $1,663,000 | +6.4% | 23,866 | +0.3% | 0.00% | +50.0% |
| Q2 2022 | $1,563,000 | +0.1% | 23,803 | +1.4% | 0.00% | 0.0% |
| Q1 2022 | $1,562,000 | -8.5% | 23,468 | -3.9% | 0.00% | 0.0% |
| Q4 2021 | $1,708,000 | +52.4% | 24,416 | +13.8% | 0.00% | +100.0% |
| Q3 2021 | $1,121,000 | -33.4% | 21,462 | -13.3% | 0.00% | -50.0% |
| Q2 2021 | $1,682,000 | -3.9% | 24,742 | +8.8% | 0.00% | 0.0% |
| Q1 2021 | $1,751,000 | +42.6% | 22,732 | +11.1% | 0.00% | 0.0% |
| Q4 2020 | $1,228,000 | +39.4% | 20,462 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $881,000 | +17.9% | 20,462 | +13.5% | 0.00% | 0.0% |
| Q2 2020 | $747,000 | +8.9% | 18,023 | +13.7% | 0.00% | 0.0% |
| Q1 2020 | $686,000 | -24.3% | 15,854 | -3.1% | 0.00% | -50.0% |
| Q4 2019 | $906,000 | +59.5% | 16,357 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $568,000 | +4.6% | 16,357 | +21.2% | 0.00% | 0.0% |
| Q2 2019 | $543,000 | – | 13,491 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,896,645 | $150,252,217 | 6.15% |
| S Squared Technology, LLC | 108,215 | $8,572,792 | 5.80% |
| Frazier Life Sciences Management, L.P. | 999,737 | $79,199,165 | 4.92% |
| First Light Asset Management, LLC | 473,691 | $37,525,801 | 3.48% |
| Ikarian Capital, LLC | 165,900 | $13,142,598 | 3.17% |
| Soleus Capital Management, L.P. | 188,217 | $14,910,551 | 2.14% |
| Integral Health Asset Management, LLC | 115,000 | $9,110,300 | 1.91% |
| Nicholas Investment Partners, LP | 267,089 | $21,158,791 | 1.85% |
| Artal Group S.A. | 400,000 | $31,688 | 1.77% |
| Avoro Capital Advisors LLC | 1,410,000 | $111,700,200 | 1.67% |